BT Lab
SKU:E4238hu
Human Glutathione S-transferase Mu 1,GSTM1 ELISA Kit
Human Glutathione S-transferase Mu 1,GSTM1 ELISA Kit
Couldn't load pickup availability
Contact us for 48 wells and bulk quote
The Human Glutathione S-Transferase Mu 1, GSTM1 ELISA Kit is a highly reliable and accurate diagnostic tool designed for the quantitative measurement of Glutathione S-Transferase Mu 1 (GSTM1) in human samples. This ELISA kit utilizes a solid-phase enzyme-linked immunosorbent assay technique, ensuring precise and reproducible results.
GSTM1 is a crucial enzyme involved in the detoxification process, playing a significant role in the metabolism of various xenobiotics and carcinogens. The measurement of GSTM1 levels is essential in assessing an individual's susceptibility to certain diseases, including cancer and cardiovascular disorders.
This ELISA kit offers a user-friendly and efficient workflow, enabling researchers and clinicians to obtain rapid and precise results. The kit includes all necessary components, including pre-coated microplate wells, standards, controls, and reagents, ensuring convenience and accuracy in every experiment.
The Human Glutathione S-Transferase Mu 1, GSTM1 ELISA Kit exhibits excellent sensitivity and specificity, allowing for the detection of GSTM1 in a wide range of human samples. The assay has a broad dynamic range, ensuring accurate quantification of GSTM1 levels even in samples with low concentrations.
With its high precision and reliability, this ELISA kit is an indispensable tool for researchers and healthcare professionals involved in studying GSTM1 and its implications in various diseases. Its robust performance and ease of use make it an ideal choice for laboratories seeking accurate and efficient GSTM1 quantification.
In summary, the Human Glutathione S-Transferase Mu 1, GSTM1 ELISA Kit offers a comprehensive solution for the quantitative measurement of GSTM1 in human samples. Its exceptional sensitivity, specificity, and user-friendly design make it an invaluable asset in research and clinical settings, facilitating advancements in the understanding and management of diseases associated with GSTM1.
Share
